Warren, R., Sofen, H., Imafuku, S., Szepietowski, J., Blauvelt, A., Spelman, L., Toms, J., Buck, A., Banerjee, S. and Menter, A. (2022) “Deucravacitinib long-term efficacy and safety in plaque psoriasis: 2-year results from the phase 3 POETYK PSO program”, SKIN The Journal of Cutaneous Medicine, 6(6), p. s48. doi: 10.25251/skin.6.supp.48.